Skip to main content

Cancer Moonshot℠ - Funding by Research Category

To ensure the Cancer Moonshot goals and approaches were grounded in the best science, NCI convened a Blue Ribbon Panel (BRP) of scientific experts as a working group to the National Cancer Advisory board. In September of 2016, the BRP presented a final report outlining 10 research recommendations that represent areas that are well-positioned to accelerate progress in cancer prevention, diagnosis, treatment and care.

Download the Data

The following research categories align with these 10 recommendations:

Cancer Moonshot by Category, FY 2021
(Whole Dollars)
Research Category Amount1
Network for Direct Patient Engagement     $53,968,535
Cancer Immunotherapy Translational Science Network    


Therapeutic Target Identification to Overcome Drug Resistance    


A National Cancer Data Ecosystem for Sharing and Analysis    


Fusion Oncoproteins in Childhood Cancers    


Minimize Cancer Treatment’s Debilitating Side Effects


Prevention and early detection: Implementation of Evidence-Based Approaches


Retrospective Analysis of Biospecimens form Patients Treated with Standard of Care


Generation of Human Tumor Atlases


Development of New Enabling Cancer Technologies


Other Cancer Moonshot priority activities (e.g., Partnership for Accelerating Cancer Therapies)


Total $206,235,789

1 Includes new obligations and recoveries from fiscal years 2017, 2018, 2019 and 2020 carryover accounts.  


  • Posted: